Jarvik Heart
NY - New YorkBiotechnology
Focus: Jarvik Heart is a specialized medical device company focused on valveless ventricular assist devices (VADs) for heart failure treatment. The company operates as a private biotech firm founded in 1988 with a narrow but critical focus in cardiovascular care.
Profile data last refreshed 4d ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
0
About Jarvik Heart
AI assessmentNot HiringNo open roles listed right now. Follow Jarvik Heart to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Jarvik 2000 VAS
Heart FailureClinical Trials (1)
NCT01627821Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
N/AHelp build intelligence for Jarvik Heart
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.